Chubb is the world's largest publicly traded property-and-casualty insurer, writing commercial and high-net-worth personal P&C, plus reinsurance and a fast-growing Asian life business, across 54 countries from its Zurich base. Its core business is pricing and carrying risk: it collects premiums today and pays claims later, and it makes money two ways — an underwriting profit when claims plus expenses come in below premiums (its 'combined ratio'), and investment income on the large bond portfolio it holds against future claims (its 'float'). What sets Chubb apart is underwriting discipline: run by Evan Greenberg, it consistently posts one of the industry's lowest combined ratios (Q1 2026 P&C combined ratio 84.0%), meaning it earns an underwriting profit where many rivals only break even, and it compounds book value per share through the cycle rather than chasing premium in soft markets. Berkshire Hathaway holds a large stake. For a reader, think of it as the blue-chip, best-in-class risk underwriter — quality and durability over growth.
Lifecycle: Mature / cash-cow financial. Chubb is scored on insurance economics — combined ratio, ROE/ROTE, book-value-per-share growth, reserve adequacy and investment income — not on industrial metrics (no EV/EBITDA, FCF or gross margin, which are structurally meaningless for an insurer whose 'inventory' is money and whose claims are paid years after premiums are collected).
| Sub-signal | Value | Score | Note |
|---|---|---|---|
| Combined ratio (underwriting) | 84.0% (Q1'26) | 92 | Best-in-class; industry median ~99% |
| Core operating ROE | 13.7% (FY25) | 78 | >10% healthy; ROTE 20.5% (goodwill-adjusted) |
| Book value / share growth | +15.8% YoY (TBVPS +21.5%) | 88 | The core thesis — tangible book compounding through the cycle |
| Net investment income | Rising (higher-for-longer float) | 80 | Large bond portfolio reinvesting at higher yields |
| Balance-sheet strength | D/E 0.24×, int-cov 14.6×, A- | 82 | Strongly capitalised; active buyback |
Moat score ≈ 70 (switching-cost and cost-advantage sub-scores derived from the Competitive Environment read below).
| Rival | Threat type | Share trajectory (Chubb vs rival) | Moat-erosion vector |
|---|---|---|---|
| Travelers (TRV), AIG | Direct commercial P&C | Stable | Price competition in softening commercial property |
| Arch Capital (ACGL), W.R. Berkley (WRB) | Specialty / E&S underwriters | Stable | Aggressive appetite for risks in the softening cycle |
| Markel (MKL), Zurich, global reinsurers | Reinsurance / specialty | Stable | Record reinsurance capital pushing property rates down 10–30% |
Net effect on moat: the soft market is an industry-wide pricing headwind, not a Chubb-specific share loss — Greenberg has publicly called the property softening 'dumb' and is choosing to shrink underpriced lines rather than chase premium, which protects the combined ratio at the cost of near-term growth. → Switching Costs held at 65, Cost Advantage 78. competitive_share_trajectory = stable; competitive_threat_level = moderate (elevated specifically in commercial property pricing).
ROIC / capital allocation: disciplined — steady dividend growth (a dividend aristocrat, 32+ years of increases), large buybacks executed below intrinsic value, reinvestment at high underwriting returns. Management skin-in-the-game solid; Greenberg is a long-tenured owner-operator. FMP rates the name A- (overall 4/5).
Insurer valuation lens — P/Book (justified P/TBV anchor), NOT P/E as the primary metric. For an insurer, earnings are volatile from catastrophe timing and mark-to-market swings on the investment book, so the primary anchor is the warranted book multiple; P/E is a cross-check, and FCF/EV-EBITDA are not meaningful (an insurer doesn't generate industrial free cash flow).
| Lens | Value | Read |
|---|---|---|
| Warranted-multiple anchor (P/B) | 1.81× vs 2.57× (0.70×) | Attractive |
| Clean / core trailing P/E | ~13.9× (FY25 core $24.79) / ~12.7× fwd | Cheap vs quality-compounder norms |
| Reported P/E (TTM) | 12.1× | Low |
| Dividend yield | ~1.14% (dividend aristocrat, growing) | Modest but rising; cash-return anchor for insurers = div + book growth |
| Analyst consensus target | $354.64 consensus / $363 median (11 recent) | ~3–6% above spot — fairly valued to mild upside per the Street |
Implied-growth colour: at 12× clean earnings and 0.70× of its warranted book multiple, the market is pricing Chubb for little real growth — essentially a mid-teens-ROE run-rate with no premium for its best-in-class combined ratio. Our disciplined estimate (6% book compounding + steady buyback) sits above that, so the price embeds less growth than the fundamentals support.
Chubb's fortunes sit above its own execution on three external forces: the P&C pricing cycle, catastrophe-loss experience, and investment yields on its float. These pull in opposite directions right now, which is why the driver lands Neutral (62), not a clean tailwind.
| Horizon | Read | Label |
|---|---|---|
| Historical (25%) | A multi-year hard market lifted rates and combined ratios; Chubb compounded book at double digits. Investment yields rose with the Fed and are being locked in. | Tailwind |
| Current (50%) | The commercial P&C market has turned soft — Q1'26 overall premiums −1.2% (ending a 33-quarter streak), commercial property −5.5%, driven by record reinsurance capital and a mild 2025 hurricane season. Offsetting: casualty/liability still firm (umbrella +11%, auto +5.8%) and higher-for-longer keeps float income rising. Chubb is shrinking underpriced property rather than chasing it. | Mixed / Neutral |
| Forward (25%) | Softening property pricing is a near-term growth headwind; the offset is a rising net-investment-income base and disciplined reserve releases. A benign cat year helps; a big-cat year is the swing risk. | Neutral |
Amplification role: driver score 62 is in the 36–64 no-amplification band — it does NOT lift the Medium BUY to STRONG BUY (which would require ≥ 65 AND a Tailwind economy AND a non-Full valuation band). The base BUY/HOLD signals stand unchanged. The softening pricing cycle is the live near-term risk that keeps this a plain BUY, not a table-pounder.
The 2026-07-14 macro report signals XLF (Financials) Short O / Medium O / Long N, capital flow 'in' (real+fast). The higher-for-longer regime is a direct tailwind for a large-bond-portfolio insurer: rising reinvestment yields lift net investment income on Chubb's float in real money terms. Stance Trend-Following (aligned with the sector's Outperform signal); Long fades to Neutral as the rate tailwind is expected to plateau. Pressure = Tailwind (feeds the amplification layer), but the Underlying Driver at 62 < 65 blocks the STRONG BUY — both conditions must hold.
Source: sector-map (GICS Financials → XLF) · Macro report 2026-07-14
The higher-timeframe trend is constructive — monthly, weekly and daily are all in uptrends with a resistance breakout and price near the 52-week high ($365.29 high; spot $343.70) — but near-term momentum is fading: the daily MACD histogram has rolled negative (−1.06), daily RSI is a neutral 47.8, and price sits just under its 20-day EMA. Confluence reads 'strongly bullish' on the trend structure, but the short-term entry is unconfirmed and a Q2 earnings print lands in 5 days.
Relative strength: ~+27% one-year total return, +11.7% YTD — a leader, not a laggard. Risk-reward: nearest daily support ~$333/$321; a pullback into that zone (or a post-earnings reclaim of the 20-day on volume) is the cleaner entry than chasing into the print. Timing confidence is capped at 40% by the earnings gate.
| Date | Event | Impact | Forecast | Previous | Relevant? | Why |
|---|---|---|---|---|---|---|
| 2026-07-21 | Chubb Q2 2026 earnings | High | EPS est $6.77 | Q1 core $6.82 | ✅ Yes | Binary event for CB — combined ratio, cat losses, NII trajectory and buyback pace all reported |
| late Jul | FOMC (rate path) | Medium | Hold likely | — | ⚠ Medium | Financials are high-macro-sensitivity; rate path drives float/investment income |
| Date | Event | Actual | Forecast | Surprise | Impact | |
|---|---|---|---|---|---|---|
| 2026-07-15 | PPI MoM (Jun) | −0.3% | — | cooler | Low | Soft — supports higher-for-longer-then-ease; neutral for CB |
| 2026-07-16 | Retail Sales MoM (Jun) | +0.2% | +0.2% | inline | Low | Steady consumer; benign for P&C exposure |
One high-impact event dominates: Q2 earnings on 21 Jul (5 days out). This is the reason Timing confidence is capped and the Short can't be confirmed pre-print — and it sets the next-update date (22 Jul, earnings +1 trading day).
| Timeframe | Trend | Direction | RSI | MACD | Key S/R | Breakout | Vol |
|---|---|---|---|---|---|---|---|
| Monthly | Uptrend ↑ | Bullish | 65.9 | + rising | S $252 / R $346 | Resist breakout | 0.6× |
| Weekly | Uptrend ↑ | Bullish | 58.5 | + rising | S $264 / R $346 | Resist breakout | 1.0× |
| Daily | Strong uptrend ↑ | Neutral | 47.8 | − falling | S $321 / R $365 | Above 200-DMA | 1.1× |
| Hourly | Weakening → | Neutral | 52.2 | − turning up | S $334 / R $358 | — | 0.1× |
| 15-min | Recovering → | Neutral | 64.0 | + flat | S $336 / R $344 | — | — |
| Confluence: Strongly bullish trend structure, short-term momentum fading · MTF Score 66 | |||||||
Monthly and weekly are cleanly bullish (price above rising MAs, resistance breakout), and daily is above its 200-DMA in a long-term uptrend — the secular direction is up. But daily MACD has rolled negative and intraday timeframes are weak, consistent with a short-term pullback within a larger uptrend ahead of earnings. The cleaner entry is a pullback into $333–$321 daily support or a post-print reclaim of the 20-day EMA on volume, not a chase into the 21 Jul report.
CB weekly closes with 50-period average. Price broke out to near its 52-week high; primary uptrend intact, daily momentum cooling into earnings. Support $333/$321; resistance the 52-week high $365 and the $363 median analyst target.
Q2 beats on a sub-87% combined ratio and rising NII; a benign hurricane season (mild 2026) keeps cat losses low; casualty pricing stays firm and buybacks continue. Book value compounds double-digits and the multiple re-rates modestly toward peers. ~$410 (12m).
Chubb defends its elite combined ratio (mid-80s) by shrinking underpriced property while casualty and Asian life carry growth; NII keeps rising on higher-for-longer. Book compounds ~high-single/low-double digits; modest multiple lift toward the $363 median target. ~$375 (12m).
The soft market deepens — commercial property rates fall 10–30% and competition (TRV/ACGL/WRB) pressures share and margin; a major-cat year (a bad hurricane season) drives the combined ratio above 95%; and/or a sharp equity/credit drawdown hits the investment book. Combined ratio deterioration + a de-rating take it to ~$290.
Forecast: Technical group: a 20-day reclaim on volume or a pullback into $333/$321 is realistic within ~1–3 weeks, most likely triggered by the 21 Jul print — CONFIDENCE Moderate (trend up, momentum cooling; the earnings reaction resets the clock either way). Catalyst group: resolves 21 Jul — CONFIDENCE Moderate, Chubb has a strong beat history but the reaction is binary. Fundamental group: becomes clean-met once the earnings window passes (after 21 Jul), assuming price stays below ~$367 — CONFIDENCE High.
Forecast: Stop-Loss: unlikely in the next 4–6 weeks — $315 is ~8% below spot and below the 200-DMA; would require an earnings miss or a sector selloff. RISK TRIGGER: 21 Jul earnings — a combined-ratio miss or a big-cat pre-announcement could gap price toward support. Thesis Invalidation: not live — combined ratio is elite (84%) and discipline intact.
Position sizing not computed — specify your portfolio allocation and role for sizing guidance.
{
"ticker": "CB",
"date": "2026-07-16",
"version": "v6",
"exchange": "NYSE",
"exchange_ticker": "NYSE:CB",
"isin": "CH0044328745",
"api_ticker": "CB",
"company": "Chubb Limited",
"currency": "USD",
"sector": "Financials",
"sub_industry": "Insurance \u2014 Property & Casualty",
"lifecycle_stage": "mature",
"price_at_rating": 343.7,
"signal_short": "HOLD",
"signal_medium": "BUY",
"signal_long": "BUY",
"primary_signal": "BUY",
"quality_score": 84,
"valuation_score": 74,
"timing_score": 52,
"driver_score": 62,
"overall_confidence": 40,
"economic_alignment_stance": "Trend-Following",
"economic_alignment_conviction": 70,
"economic_alignment_pressure": "Tailwind",
"economic_alignment_source": "sector-map",
"macro_report_date": "2026-07-14",
"val_multiple_basis": "P/TBV",
"warranted_multiple": 2.57,
"actual_multiple": 1.81,
"warranted_ratio": 0.7,
"val_band": "attractive",
"discount_rate_r": 0.09,
"risk_free_10y": 0.045,
"g_near": 0.06,
"g_term": 0.03,
"actual_ptbv_reported": 2.71,
"guardrail_note": "reported P/TBV 2.71x ($343.70/$126.65) is below the insurer 3.0x rich line, so no goodwill-driven false rich read is at risk; primary anchor is P/Book 1.81x vs justified 2.57x = 0.70x Attractive; TBV cross-check pairs 2.71x with ROTE ~20.5% -> justified P/TBV ~4.8x, again Attractive",
"nonop_pct_of_net_income": -16.0,
"clean_pe": 13.9,
"clean_peg": null,
"nonop_note": "Reverse of the usual trap \u2014 Q1'26 net income REDUCED by $1.94B after-tax MTM bond losses; core operating EPS $6.82 > net EPS $5.88, so clean/core earnings are higher than headline. Scored on core.",
"combined_ratio": 84.0,
"core_operating_roe": 13.7,
"rote": 20.5,
"bvps": 189.93,
"tbvps": 126.65,
"bvps_growth_yoy": 15.8,
"competitive_share_trajectory": "stable",
"competitive_threat_level": "moderate",
"driver_commodity_trend": null,
"hard_gate_state": "\u26a0 caution",
"gates_triggered": [
"Earnings Event Risk (21 Jul, timing conf capped 40%)"
],
"do_not_buy_triggers": [],
"entry_groups_met": 0,
"entry_conviction": "Wait",
"exit_groups_live": 0,
"exit_action": "Hold",
"short_entry_confirmed": false,
"short_cap_reason": "Short base signal capped to HOLD \u2014 Technical AND Catalyst entry groups both UNMET (Fundamental also blocked by earnings within 7d); a short-term BUY needs a confirmed technical/catalyst path. Buy on confirmation: a 20-day reclaim on volume or a pullback into $333/$321, ideally post-21-Jul print.",
"fair_value_est": 367.0,
"stop_loss": 315.0,
"target_price": 375.0,
"scenario_base_target": 375,
"scenario_bull_target": 410,
"scenario_bear_target": 290,
"next_update_date": "2026-07-22",
"next_update_basis": "earnings 2026-07-21 +1 trading day",
"next_check_date": "2026-07-22",
"analysis_status": "starting",
"finder_ticker": "CB",
"finder_exchange": "\ud83c\uddfa\ud83c\uddf8 NYSE"
}